Xylem grants CFO 1,693 RSUs and 6,034 options
Xylem’s CFO received new restricted stock units and stock options that vest over three years, increasing her direct equity stake.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Xylem Inc. (XYL) reported equity awards to EVP & Chief Financial Officer Andrea Michele van der Berg. On September 1, 2026, she received 1,693 shares of common stock as restricted stock units and 6,034 non-qualified stock options with an exercise price of $106.89 per share, all vesting in one-third increments on March 1, 2027, 2028, and 2029. Following these awards, she directly holds 10,691 shares of common stock and 6,034 stock options expiring on September 1, 2036, and no Rule 10b5-1 trading plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) F2 | 6,034 | $106.89 | $645K |
| Grant/Award | Common Stock F1 | 1,693 | $0.00 | $0.00 |
Footnotes (2)
- F1. Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
- F2. Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
Key Figures
Key Terms
restricted stock units financial
non-qualified stock options financial
vesting financial
Omnibus Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Xylem (XYL) grant to its CFO on September 1, 2026?
What are the key terms of the CFO’s new Xylem (XYL) stock options?
Were the September 1, 2026 Xylem (XYL) equity awards made under a specific plan?
Were Xylem (XYL) CFO’s September 1, 2026 transactions under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.